Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of QNCX will decline by -93.74% over the next 2 Weeks and hit $0.01 by Thursday, April 16, 2026. In that time frame, QNCX's share price is expected to range between $0.00 and $0.11.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 16, 2026 | 0.00 | 0.04 | 0.14 |
| Apr 15, 2026 | 0.01 | 0.12 | 0.22 |
| Apr 14, 2026 | 0.00 | 0.10 | 0.21 |
| Apr 13, 2026 | 0.00 | 0.05 | 0.16 |
| Apr 10, 2026 | 0.00 | 0.06 | 0.17 |
| Apr 9, 2026 | 0.00 | 0.07 | 0.18 |
| Apr 8, 2026 | 0.04 | 0.15 | 0.26 |
| Apr 7, 2026 | 0.02 | 0.13 | 0.23 |
| Apr 6, 2026 | 0.00 | 0.08 | 0.19 |
| Apr 3, 2026 | 0.00 | 0.09 | 0.20 |
QNCX shares fell -3.23% in Thursday, April 2, 2026's trading session, dropping from a previous close of $0.10 to move at $0.10. The stock demonstrated notable intraday movement (see QNCX's key stats for a full breakdown), fluctuating between $0.09 and $0.10, a +7.53% trading range. While recent weeks have seen some volatility, QNCX has managed to secure a +12.88% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 8.48M shares changing hands, 5.05M fewer than the previous session. This amounted to $839.54K in total market activity.
Will QNCX Continue Its Upward Trend?
According to analyst ratings and projections for QNCX, Quince Therapeutics, Inc. shares are anticipated to increase by +30.75%, potentially reaching $0.14 per share by April 16, 2026. Short-term technical indicators for QNCX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 20 negative trading days within the past 30 sessions. Based on the QNCX stock forecast, now is a good time to buy QNCX stock because its current trading price is +155.15% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on QNCX covering social and institutional perspectives.
QNCX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into QNCX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 31.61% to 38.87%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 37.96%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 42.41%, maintains a neutral outlook for the long term. Insights into QNCX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Quince Therapeutics Short-Term Forecasts
QNCX Forecast For Next 5 Days
Our algorithm anticipates Quince Therapeutics (QNCX) stock could hit $0.00 by Apr 10, 2026. This represents a - rise from today's price, following a +15.93% change over the past five days.
QNCX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Quince Therapeutics, Inc. (QNCX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.00, which would mean a -100.00% decrease from the current price of $0.10. Projections for this period range from a high of $0.19 to a low of $0.00.
QNCX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Quince Therapeutics's price over the next three months point to a rise. QNCX stock is expected to peak at $0.73 on Apr 07, 2026 before potentially dipping to $0.00 on Jul 03, 2026. On average, QNCX is likely to trade around $0.17 in the coming 90 days.
Quince Therapeutics Stock Forecast 2025
Based on our predictive models, Quince Therapeutics (QNCX) is expected to trade between $0.00 and $0.73 throughout 2026. This would result in an average price of $0.30, potentially offering investors a +203.03% return from current levels.
Quince Therapeutics, Inc. Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Quince Therapeutics, Inc. (QNCX) is positioned to show a strong performance in April 2026. The price is predicted to move between $0.00 and $0.73, settling at an average of $0.29. This could translate to a +192.93% gain.
May 2026
Based on current market signals, Quince Therapeutics, Inc. is projected to trend may 2026. We forecast a trading range from $0.02 to $0.40, with a likely average price of $0.19. Investors could expect a potential return of +91.92%.
June 2026
Our predictive algorithms indicate Quince Therapeutics, Inc. stock may see a shift in June 2026. The expected range spans $0.00–$0.25, with an average target of $0.08. This represents a cautious outlook and a possible loss of -19.19%.
July 2026
Analyzing established trends, Quince Therapeutics, Inc. looks set to move in July 2026. Projections place the stock between $0.00 and $0.12, averaging around $0.00. This suggests a -100.00% loss from current levels.
August 2026
Market indicators suggest Quince Therapeutics, Inc. could experience notable changes during August 2026. Prices could fluctuate within $0.00 to $0.05, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
September 2026
Forecasting for September 2026, models estimate that Quince Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.28, averaging $0.09. This signals a cautious trajectory with potential returns around -9.09%.
October 2026
According to our latest forecast models, Quince Therapeutics, Inc. (QNCX) is positioned to show a strong performance in October 2026. The price is predicted to move between $0.00 and $0.29, settling at an average of $0.37. This could translate to a +273.74% gain.
November 2026
Based on current market signals, Quince Therapeutics, Inc. is projected to trend november 2026. We forecast a trading range from $0.00 to $0.13, with a likely average price of $0.62. Investors could expect a potential return of +526.26%.
December 2026
Our predictive algorithms indicate Quince Therapeutics, Inc. stock may see a shift in December 2026. The expected range spans $0.00–$0.00, with an average target of $1.06. This represents a positive outlook and a possible gain of +970.71%.
January 2027
Analyzing established trends, Quince Therapeutics, Inc. looks set to move in January 2027. Projections place the stock between $0.00 and $0.00, averaging around $0.62. This suggests a +526.26% gain from current levels.
February 2027
Market indicators suggest Quince Therapeutics, Inc. could experience notable changes during February 2027. Prices could fluctuate within $0.00 to $0.03, with a midpoint forecast of $0.10. The stock might deliver a +1.01% gain.
March 2027
Forecasting for March 2027, models estimate that Quince Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.08. This signals a cautious trajectory with potential returns around -19.19%.
April 2027
According to our latest forecast models, Quince Therapeutics, Inc. (QNCX) is positioned to show a strong performance in April 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.08. This could translate to a -19.19% loss.
QNCX's history of dividends and stock splits also plays a role in long-term investor confidence.